In a recent press release, Ro — a healthcare company — announced that it will partner with the National Institute of Aging, a subset of the NIH, to use its telehealth platform to diversify...
Using data from ClinicalTrials.gov, researchers collected data on eligibility criteria from approximately 100 clinical research protocols. Of the 97 interventional studies, 14 focused on dementia, 24...
Today, Walmart joined many other companies to improve clinical research for marginalized communities by launching its clinical research mission. The Walmart Healthcare Research Institute (WHRI) will be...
As the rate of chronic disease in the United States continues to rise, industry members are looking for new and effective methods to manage and treat these disorders. The Pharmaceutical Research and...
For many minority communities, marijuana possession and use can lead to years of incarceration for nonviolent offenses. The Biden administration has recognized that the harsh punishment around...
In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...
According to the Cleveland Clinic, approximately 1 in 10 people in the United States have liver disease. Current diagnostic methods for liver disease have proven ineffective in early diagnosis. Oncoustics is one of many companies looking...
FDA recently issued draft guidance to enroll more participants from underrepresented racial and ethnic populations in the United States into trials, expanding overall clinical trial...
Moderna recently launched the Moderna Charitable Foundation to promote public health, access to quality healthcare, and educational opportunities, particularly in underserved populations.
The...
Johnson & Johnson recently announced a series of initiatives in high tuberculosis (TB) burden countries to empower a generation of youth to end TB and increase disease detection.
The...
The CDC Advisory Committee on Immunization Practices (ACIP) recently recommended Pfizer’s tick-borne encephalitis (TBE) vaccine, TicoVac, to prevent TBE in individuals one year and older.
ACIP...
Abbott and the American Diabetes Association (ADA) recently launched a joint community health partnership to address diabetes care management among people of color (POC) living with the...
Abbott recently launched a new initiative to increase clinical trial diversity in medical research through training, education, and improved clinical research infrastructure throughout the...
Black Americans are still significantly underrepresented in cardiovascular disease clinical trials, and enrollment rates have not improved over time, according to a new paper published in the Journal...
Health equity is crucial to ensuring access for all individuals to essential care. And pharmaceutical and biotechnology companies are pushing for necessary long-term changes to better meet the needs of...
Health2047, a subsidiary of the American Medical Association (AMA), recently spun out SiteBridge Research to boost clinical trial access for small and community physician practices.
SiteBridge...
The Biden Administration recently released new prescription drug policy priorities that focus on addressing the opioid epidemic and reducing drug overdoses.
The priorities provide guideposts to...
Diversity in clinical trials is critically important for developing therapies that reflect the real world, which includes many ethnic, racial, and other populations.
But oftentimes clinical...
Eight top pharmaceutical companies are moving to systematically enhance their drug development pipeline, with plans to boost access to products in low-and middle-income countries, according to the 2021...
HHS recently announced three ways the federal government will continue to support COVID-19 testing efforts by states and authorities into 2021.
The initiative builds upon over $31 billion in...
